SAN FRANCISCO--(BUSINESS WIRE)--Journey Colab, a biopharmaceutical company unlocking the science of psychedelics to build a new model of addiction care, today announced the appointment of Joel A. Posener, MD as Chief Medical Officer. Dr. Posener previously served as Vice President, Clinical Research at Neumora Therapeutics. The company is utilizing synthetic Mescaline HCl (JOUR-5700) to develop a therapeutic for Alcohol Use Disorder (AUD).